Physical activity and the frequency of acute exacerbations in patients with chronic obstructive pulmonary disease

M Schönmann, N A Sievi, C F Clarenbach, T Brack, M Brutsche, M Frey, S Irani, J D Leuppi, J Ruediger, O Senn, R Thurnheer, M Kohler, M Schönmann, N A Sievi, C F Clarenbach, T Brack, M Brutsche, M Frey, S Irani, J D Leuppi, J Ruediger, O Senn, R Thurnheer, M Kohler

Abstract

Purpose: Acute exacerbations (AE) in patients with COPD are associated with a decline in lung function, increased risk of hospitalization, and mortality. In this cross-sectional study we tested whether the level of objectively measured daily physical activity and exercise capacity are associated with the number of COPD exacerbations.

Methods: In 210 patients with COPD (67 % men; mean (SD) age: 63 (8) years) enrolled in The Obstructive Pulmonary Disease Outcomes Cohort of Switzerland (TOPDOCS) physical activity (PA) (steps per day, physical activity level, (PAL)), exercise capacity (6-min walking distance, (6MWD)), comorbidities, lung function, and medication were assessed. Differences between COPD patients with frequent (≥2 year) and infrequent (0-1 year) exacerbations were assessed. Univariate and multivariate analyses were performed to investigate whether the level of objectively measured daily physical activity and exercise capacity are associated with the number of COPD exacerbations.

Results: Patients with frequent AE had a significantly lower FEV1 and 6MWD compared to patients with infrequent AE. In univariate analysis, the number of exacerbations was inversely associated with FEV1, 6MWD, BMI, and smoking status while there was a positive association with RV/TLC and combined inhaled medication. However, there was no significant association with PAL and steps per day. In multivariate analysis, FEV1 and the use of combined inhaled medication were independently associated with the number of AE, after correction for covariates.

Conclusions: The findings of this study imply that FEV1, independent of inhaled medication, is significantly associated with COPD exacerbations. Neither physical activity nor exercise capacity was independently associated with COPD exacerbations.

Trial registration: ClinicalTrials.gov NCT01527773.

References

    1. Eur Respir J. 2009 Feb;33(2):262-72
    1. Chest. 2007 Mar;131(3):696-704
    1. Thorax. 2006 Sep;61(9):772-8
    1. Chest. 2009 Jul;136(1):62-70
    1. Thorax. 2005 Nov;60(11):925-31
    1. Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
    1. N Engl J Med. 2011 Sep 29;365(13):1184-92
    1. Circulation. 1999 May 11;99(18):2434-9
    1. Int J Tuberc Lung Dis. 2012 Aug;16(8):1015-9
    1. Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1418-22
    1. Int J Behav Nutr Phys Act. 2012 Jun 12;9:71
    1. Thorax. 2003 Feb;58(2):100-5
    1. Chest. 2007 Jul;132(1):127-34
    1. Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):959-67
    1. Chest. 2012 Aug;142(2):338-346
    1. Public Health Nutr. 2006 Apr;9(2):258-65
    1. Eur Respir J. 2005 Aug;26(2):319-38
    1. PLoS One. 2012;7(11):e48081
    1. Respir Med. 2012 Apr;106(4):522-30
    1. Am J Respir Crit Care Med. 2005 Mar 1;171(5):446-52
    1. JAMA. 2006 Jul 12;296(2):171-9
    1. Br J Sports Med. 2010 Aug;44(10):741-6
    1. Eur Respir J. 2005 Aug;26(2):234-41
    1. Thorax. 2006 Feb;61(2):164-8
    1. Am J Respir Crit Care Med. 2007 Dec 15;176(12):1208-14
    1. Respir Res. 2010 Sep 10;11:122
    1. Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55
    1. N Engl J Med. 1992 Dec 31;327(27):1893-8
    1. Int J Chron Obstruct Pulmon Dis. 2009;4:245-51
    1. Proc Am Thorac Soc. 2011 Aug;8(4):334-7
    1. N Engl J Med. 2010 Sep 16;363(12):1128-38
    1. Hypertension. 2001 May;37(5):1236-41
    1. Am J Respir Crit Care Med. 2001 Aug 1;164(3):358-64

Source: PubMed

3
Se inscrever